1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 16 FEBRUARY 2015

Cancer Drug News 16 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio
Industry Brief - Kinex Licenses BCRP-Targeted Patents From Hong Kong Polytechnic University/McGill University
Industry Brief - Lion Obtains Licence From NIH To Develop TIL Therapy In MM
Industry Trend Analysis - Takeda Can Replicate Velcade's Success With Ixazomib
Industry Brief - Peregrine's PS-Targeting Antibodies Significantly Enhance Antitumour Activity
Industry Brief - Aduro Achieves First Milestone In Janssen Collaboration For PCA
Industry Brief - Breckenridge Initiates Cabazitaxel Patent Challenge
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For OC
Industry Trend Analysis - US Generic Sorafenib Revenues Will Be Small, But Global Prospects Are Attractive
Industry Brief - CASI Receives Final Minutes From FDA Meeting For ENMD-2076 Clinical/Regulatory Path In FLC
Industry Brief - Merck Takes Full Promotional Responsibility For Erbitux In Japan
Industry Trend Analysis - Lenvima TC Approval Provides Option For Large Unmet Medical Need
Industry Brief - FDA Grants ODD To Verastem's VS-5584 For Mesothelioma
Industry Trend Analysis - In Vitro Diagnostics Impacting Pharmaceutical R&D
Industry Brief - NanoSmart's ANA-Conjugated Liposomal Doxorubicin Gains FDA ODD For Ewing's Sarcoma
Industry Trend Analysis - J&J Guiding Drug Development With New Research Platforms
Industry Brief - Helsinn Signs Exclusive Agreement With Mundipharma For NEPA In Brazil
Industry Brief - Orexo Files Fentanyl Patent Litigation Against Actavis
Industry Brief - CBMG Acquires CAR-T Assets From China Hospital
Industry Brief - Sanofi To Lay Off 100 Massachusetts Workers

Table Of Contents

Cancer Drug News 16 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.